Cell Cryopreservation Market, by Product Type (Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others), by Application (Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others), by End User
Description
Cell Cryopreservation Market, by Product Type (Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others), by Application (Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others), by End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028
The process of stabilizing biological materials at cryogenic temperatures (below -1500 degree C) is called cryopreservation. Cryopreservation is used for the preservation of microorganisms, tissue cells, established cell-lines, small multicellular organisms, and complex cellular structures such as embryos, nucleic acid, and proteins. Cryopreservation procedures use liquid nitrogen, liquid helium, argon, and oxygen as cryogenic elements. Various types of samples with varying sensitivity require different types of cryopreservation equipment such as cryopreservation freezers, liquid nitrogen vessels, cryogenic vaporizers, cryogenic incubators, liquid tracking equipment, and cell freezing container.
Market Dynamics
Increasing product launches by market players is a major factor driving the global cell cryopreservation market growth. For instance, in 2021, Irvine Scientific, a manufacturer of cell culture media, introduced Arctic Sperm Cryopreservation Medium to improve the post-thaw performance of frozen sperm samples and reduce the cost of sperm cryopreservation.
Furthermore, decrease in fertility rate is expected to drive the market growth. According to the Journal of Human Reproductive Sciences, 2015, around 40-80% of females face possible infertility as a result of their cancer treatments that is, chemotherapy, radiation, and surgery.
Key features of the study:
This report provides in-depth analysis of the global cell cryopreservation market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global cell cryopreservation market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Miltenyi Biotec GmbH, BioLifeSolutions Inc., HiMedia Laboratories Pvt. Ltd., PromoCell GmbH, Corning Incorporated, Cooper Companies, Inc., and Planer PLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market
Detailed Segmentation:
Global Cell Cryopreservation Market, By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
Global Cell Cryopreservation Market, By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
Global Cell Cryopreservation Market, By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
Global Cell Cryopreservation Market, By Region:
North America
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country:
U.S.
Canada
Latin America
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country/Region:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
General Electric Company*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Thermo Fisher Scientific Inc.
Merck KGaA
AMS Biotechnology (Europe) Limited
Miltenyi Biotec GmbH
BioLifeSolutions Inc.
HiMedia Laboratories Pvt. Ltd.
PromoCell GmbH
Corning Incorporated
Cooper Companies, Inc.
Planer PLC
“*” marked represents similar segmentation in other categories in the respective section.
The process of stabilizing biological materials at cryogenic temperatures (below -1500 degree C) is called cryopreservation. Cryopreservation is used for the preservation of microorganisms, tissue cells, established cell-lines, small multicellular organisms, and complex cellular structures such as embryos, nucleic acid, and proteins. Cryopreservation procedures use liquid nitrogen, liquid helium, argon, and oxygen as cryogenic elements. Various types of samples with varying sensitivity require different types of cryopreservation equipment such as cryopreservation freezers, liquid nitrogen vessels, cryogenic vaporizers, cryogenic incubators, liquid tracking equipment, and cell freezing container.
Market Dynamics
Increasing product launches by market players is a major factor driving the global cell cryopreservation market growth. For instance, in 2021, Irvine Scientific, a manufacturer of cell culture media, introduced Arctic Sperm Cryopreservation Medium to improve the post-thaw performance of frozen sperm samples and reduce the cost of sperm cryopreservation.
Furthermore, decrease in fertility rate is expected to drive the market growth. According to the Journal of Human Reproductive Sciences, 2015, around 40-80% of females face possible infertility as a result of their cancer treatments that is, chemotherapy, radiation, and surgery.
Key features of the study:
This report provides in-depth analysis of the global cell cryopreservation market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global cell cryopreservation market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Miltenyi Biotec GmbH, BioLifeSolutions Inc., HiMedia Laboratories Pvt. Ltd., PromoCell GmbH, Corning Incorporated, Cooper Companies, Inc., and Planer PLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market
Detailed Segmentation:
Global Cell Cryopreservation Market, By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
Global Cell Cryopreservation Market, By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
Global Cell Cryopreservation Market, By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
Global Cell Cryopreservation Market, By Region:
North America
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country:
U.S.
Canada
Latin America
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country/Region:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Cryoprotectant Agents
Glycerol
Dimethyl Sulfoxide (DMSO)
Others
Equipment
Incubators
Liquid Nitrogen Supply Tanks
Freezers
Others
By Application:
Stem Cells
Oocytes and Embryos
Sperm, Semen, and Testicular Tissue
Hepatocytes
Others
By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Biobank
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
General Electric Company*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Thermo Fisher Scientific Inc.
Merck KGaA
AMS Biotechnology (Europe) Limited
Miltenyi Biotec GmbH
BioLifeSolutions Inc.
HiMedia Laboratories Pvt. Ltd.
PromoCell GmbH
Corning Incorporated
Cooper Companies, Inc.
Planer PLC
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
192 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Collaboration and Acquisitions
- New Product Launches
- Regulatory Scenario
- Merger and Acquisition Scenario
- PEST Analysis
- PORTER’S Analysis
- 4. Global Cell Cryopreservation Market, By Product Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Cryoprotectant Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Glycerol
- Dimethyl Sulfoxide (DMSO)
- Others
- Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Incubators
- Liquid Nitrogen Supply Tanks
- Freezers
- Others
- 5. Global Cell Cryopreservation Market, By Application, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Oocytes and Embryos
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Sperm, Semen, and Testicular Tissue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Hepatocytes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 6. Global Cell Cryopreservation Market, By End User, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Biobank
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 7. Global Cell Cryopreservation Market , By Region, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- North America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 8. Competitive Landscape
- Company Profiles
- General Electric Company
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck KGaA
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AMS Biotechnology (Europe) Limited
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Miltenyi Biotec GmbH
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Corning Incorporated
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BioLifeSolutions Inc.
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- HiMedia Laboratories Pvt. Ltd.
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PromoCell GmbH
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cooper Companies, Inc.
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Planer PLC
- Company Overview
- Disease Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 9. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 32 market data tables and 25 figures on "Cell Cryopreservation Market - Global forecast to 2028”.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
